Phase-2 Trial of an Intensified Conditioning Regimen for Allogeneic Hematopoietic Cell Transplant for Poor-Risk Leukemia

Patients with poor-risk leukemia have a high relapse rate despite allogeneic transplant. We report on the phase II trial of an intensified allogeneic transplant regimen whose aim was tolerable toxicity and durable remission. Study patients (n=30) had unfavorable first remission cytogenetics, progres...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Stein, Anthony S., O’Donnell, Margaret R., Synold, Timothy W., Dagis, Andrew C., Tsirunyan, Anjela, Nademanee, Auayporn P., Parker, Pablo M., Pullarkat, Vinod A., Snyder, David S., Spielberger, Ricardo T., Wong, Jeffrey Y.C., Alvarnas, Joseph C., Thomas, Sandra H., Forman, Stephen J.
Format: Artigo
Idioma:Inglês
Publicat: 2010
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3203202/
https://ncbi.nlm.nih.gov/pubmed/21151180
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2010.295
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars